These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 15143188)
1. Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling. Feener EP; Rosario F; Dunn SL; Stancheva Z; Myers MG Mol Cell Biol; 2004 Jun; 24(11):4968-78. PubMed ID: 15143188 [TBL] [Abstract][Full Text] [Related]
2. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. Saharinen P; Silvennoinen O J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625 [TBL] [Abstract][Full Text] [Related]
3. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468 [TBL] [Abstract][Full Text] [Related]
4. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843 [TBL] [Abstract][Full Text] [Related]
5. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling. Robertson SA; Koleva RI; Argetsinger LS; Carter-Su C; Marto JA; Feener EP; Myers MG Mol Cell Biol; 2009 Jun; 29(12):3367-78. PubMed ID: 19364823 [TBL] [Abstract][Full Text] [Related]
7. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Valentino L; Pierre J Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581 [TBL] [Abstract][Full Text] [Related]
8. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791 [TBL] [Abstract][Full Text] [Related]
9. Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation. Ahr B; Denizot M; Robert-Hebmann V; Brelot A; Biard-Piechaczyk M J Biol Chem; 2005 Feb; 280(8):6692-700. PubMed ID: 15615703 [TBL] [Abstract][Full Text] [Related]
10. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells. Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225 [TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin signal transduction requires functional JAK2, not TYK2. Drachman JG; Millett KM; Kaushansky K J Biol Chem; 1999 May; 274(19):13480-4. PubMed ID: 10224114 [TBL] [Abstract][Full Text] [Related]
13. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase. Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147 [TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling. Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162 [TBL] [Abstract][Full Text] [Related]
15. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes. DeVito WJ; Stone S J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Yamauchi T; Ueki K; Tobe K; Tamemoto H; Sekine N; Wada M; Honjo M; Takahashi M; Takahashi T; Hirai H; Tushima T; Akanuma Y; Fujita T; Komuro I; Yazaki Y; Kadowaki T Nature; 1997 Nov; 390(6655):91-6. PubMed ID: 9363897 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947 [TBL] [Abstract][Full Text] [Related]
18. ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation. Hammarén HM; Ungureanu D; Grisouard J; Skoda RC; Hubbard SR; Silvennoinen O Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4642-7. PubMed ID: 25825724 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. McWhinney CD; Dostal D; Baker K J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424 [TBL] [Abstract][Full Text] [Related]
20. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Mazière C; Conte MA; Mazière JC Free Radic Biol Med; 2001 Dec; 31(11):1334-40. PubMed ID: 11728804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]